Javascript must be enabled to continue!
Low predictive power of clinical features for relapse prediction after antidepressant discontinuation in a naturalistic setting
View through CrossRef
1
Abstract
Background
The risk of relapse after antidepressant medication (ADM) discontinuation is high. Predictors of relapse could guide clinical decision-making, but are yet to be established.
Method
We assessed demographic and clinical variables in a longitudinal observational study before antidepressant discontinuation. State-dependent variables were re-assessed either after discontinuation or before discontinuation after a waiting period. Relapse was assessed during six months after discontinuation. We applied logistic general linear models in combination with least absolute shrinkage and selection operator and elastic nets to avoid overfitting in order to identify predictors of relapse and estimated their generalisability using cross-validation.
Results
The final sample included 104 patients (age: 34.86 (11.1), 77% female) and 57 healthy controls (age: 34.12 (10.6), 70% female). 36% of the patients experienced a relapse. Treatment by a general practitioner increased the risk of relapse. Although within-sample statistical analyses suggested reasonable sensitivity and specificity, out-of-sample prediction of relapse was at chance level. Residual symptoms increased with discontinuation, but did not relate to relapse.
Conclusion and Relevance
Demographic and standard clinical variables appear to carry little predictive power and therefore are of limited use for patients and clinicians in guiding clinical decision-making.
Title: Low predictive power of clinical features for relapse prediction after antidepressant discontinuation in a naturalistic setting
Description:
1
Abstract
Background
The risk of relapse after antidepressant medication (ADM) discontinuation is high.
Predictors of relapse could guide clinical decision-making, but are yet to be established.
Method
We assessed demographic and clinical variables in a longitudinal observational study before antidepressant discontinuation.
State-dependent variables were re-assessed either after discontinuation or before discontinuation after a waiting period.
Relapse was assessed during six months after discontinuation.
We applied logistic general linear models in combination with least absolute shrinkage and selection operator and elastic nets to avoid overfitting in order to identify predictors of relapse and estimated their generalisability using cross-validation.
Results
The final sample included 104 patients (age: 34.
86 (11.
1), 77% female) and 57 healthy controls (age: 34.
12 (10.
6), 70% female).
36% of the patients experienced a relapse.
Treatment by a general practitioner increased the risk of relapse.
Although within-sample statistical analyses suggested reasonable sensitivity and specificity, out-of-sample prediction of relapse was at chance level.
Residual symptoms increased with discontinuation, but did not relate to relapse.
Conclusion and Relevance
Demographic and standard clinical variables appear to carry little predictive power and therefore are of limited use for patients and clinicians in guiding clinical decision-making.
Related Results
Amygdala reactivity, antidepressant discontinuation and relapse: a longitudinal, observational study with a randomized component
Amygdala reactivity, antidepressant discontinuation and relapse: a longitudinal, observational study with a randomized component
Importance: Antidepressant discontinuation substantially increases the risk of a depression relapse. The neurobiological mechanisms through which this happens are not known. Amygda...
Amygdala Reactivity, Antidepressant Discontinuation, and Relapse
Amygdala Reactivity, Antidepressant Discontinuation, and Relapse
ImportanceAntidepressant discontinuation substantially increases the risk of a depression relapse, but the neurobiological mechanisms through which this happens are not known. Amyg...
Do discontinuation symptoms predict depression relapse after antidepressant cessation?
Do discontinuation symptoms predict depression relapse after antidepressant cessation?
Background: Discontinuing antidepressants after recovering from a depressive episode is associated with a risk for two events: discontinuation symptoms and relapse. Little is known...
ecision Farming and Predictive Analytics in Precision Farming and Predictive Analytics in Precision Farming and Predictive Analytics in Precision Farming and Predictive Analytics in Precision Farming and Predictive Analytics in Precision Farming and Predi
ecision Farming and Predictive Analytics in Precision Farming and Predictive Analytics in Precision Farming and Predictive Analytics in Precision Farming and Predictive Analytics in Precision Farming and Predictive Analytics in Precision Farming and Predi
The scope of sensor networks and the Internet of Things spanning rapidly to diversified domains but not limited to sports, health, and business trading. In recent past, the sensors...
The Role of Whole Body STIR MRI in Assessing First Biochemical Relapse in Patients with Myeloma
The Role of Whole Body STIR MRI in Assessing First Biochemical Relapse in Patients with Myeloma
Background: Myeloma remains an incurable disease and most patients will relapse. The optimal timing of salvage initiation remains uncertain although there is a trend to treating ea...
Risk Factors and Prognosis Analysis of Patient-Specific HLA Genomic Loss Relapse Following ATG-Based T-Cell-Replete Haploidentical Hematopoietic Stem Cell Transplantation
Risk Factors and Prognosis Analysis of Patient-Specific HLA Genomic Loss Relapse Following ATG-Based T-Cell-Replete Haploidentical Hematopoietic Stem Cell Transplantation
Abstract
Background
Developments in related haploidentical hematopoietic stem cell transplantation (haplo-HSCT) have made two immune systems with inco...
1764 – Case Report: Antidepressant Withdrawal Mania
1764 – Case Report: Antidepressant Withdrawal Mania
IntroductionAntidepressant withdrawal mania is a rare paradoxical event. It was initially reported in unipolar patients but it can also occur in bipolar patients, despite adequate ...
Delay discounting correlates with depression but does not predict relapse after antidepressant discontinuation
Delay discounting correlates with depression but does not predict relapse after antidepressant discontinuation
Background: Approximately one third of people with major depressive disorder experience a relapse within six months of discontinuing antidepressant medication (ADM), however, relia...

